European generic prescribing trends and biosimilars

Generics/Research | Posted 29/07/2009 post-comment0 Post your comment

Pressure to control pharmaceutical expenditure and price competition among pharmaceutical companies is fuelling the development of generic medicines markets in ambulatory care in Europe.

Professor Steven Simoens of the Katholieke Universiteit Leuven in Belgium wrote a special report aiming to identify, interpret and discuss the main supply and demand trends affecting the European generic medicines market in ambulatory care.

 

On the supply side, generic price-regulated systems and reference pricing systems are spreading across Europe.

 

On the demand side, European countries have attempted to stimulate demand for generic medicines by focusing on physician prescribing, generic substitution by pharmacists and patient copayments.

 

Finally, the development of biosimilars will probably become an important area of growth for the pharmaceutical industry over the next five years.

Source: Expert Rev Clin Pharmacol. 2008;1(4):497-503.

comment icon Comments (0)
Post your comment
Related content
Generic pharmaceutical policies in the MENA region
10 AA008993
Generics/Research Posted 17/09/2021
The generics market in Brazil
53 MD002445
Generics/Research Posted 16/07/2021
Most viewed articles
About GaBI
Home/About GaBI Posted 05/08/2009
EU guidelines for biosimilars
EMA logo 1 V13C15
Home/Guidelines Posted 08/10/2010